Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-28

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s oxybutynin chloride as an original ANDA (ANDA211655), a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)